Future studies are warranted to determine whether NPY/AgRP neuron inhibition contributes to the sustained antidiabetic action elicited by intracerebroventricular FGF1 injection in rodent models of T2D. This evidence concerns the gene FGF1 and type 2 diabetes mellitus.